Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk
Science Advances · 2025
DOI: 10.1126/sciadv.adr0377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Lang Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Biomarkers, Precision Medicine, Thrombosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The body weight–based thrombolytic medication strategy in clinical trials shows critical defects in recanalization rate and post-thrombolysis hemorrhage. Methods for perceiving thrombi heterogeneity of thrombolysis resistance is urgently needed for precise thrombolysis. Here, we revealed the relationship between the thrombin heterogeneity and the thrombolysis resistance in thrombi and created an artificial biomarker-based nano-patrol system with robotic functional logic to perceive and report the thrombolysis resistance of thrombi. The nano-patrols are contrallable and are able to accomplish thrombolysis resistance-matched personalized and precise therapy according to the feedback signal from artificial biomarkers. This nano-patrol system depicted more enhanced thrombolytic efficiency (elevated by 25%) than alteplase for mini pig model and clinical thrombi and achieved recanalization in thrombotic model where alteplase encountered failure. Moreover, the nano-patrol remarkably reduced the infarct volume and the hemorrhagic transformation risk (0.12-fold of alteplase) of cerebral thrombosis. Therefore, we developed a unique tool for diagnosing thrombolysis resistance and achieving personalized and precise thrombolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Third Military Medical University, Chongqing, China.
- Jinfeng Laboratory, Chongqing, China.
- State Key Laboratory of Trauma and Chemical Poisoning, Chongqing, China.
- School of Medicine, Chongqing University, Chongqing, China.
- Advanced Photonics Center, School of Electronic Science and Engineering, Southeast University, Nanjing, China.
- Department of Neurology, Southwest Hospital, Third Military Medical University, Chongqing, China.
ORCID-Profile: Lang Li, Hao Tian, Liulin Wu, Na Chen, Qiao Zhang, Lin Chen, Kai Zhu, Lin Lin, Xi Chen, Lang He, Min Liu, Wenyan Zhao, Yang Su, Juan Yan, Xingli Zhao, Xin Zhou, Zhenhua Zhou, Wen Zeng
Zitieren
APA
Li, L., Tian, H., Wu, L., Chen, N., Zhang, Q., Chen, L., Zhu, K., Lin, L., Chen, X., He, L., Liu, M., Zhao, W., Su, Y., Yan, J., Zhao, X., Zhou, X., Zhou, Z., & Zeng, W. (2025). Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk. Science Advances. https://doi.org/10.1126/sciadv.adr0377
Vancouver
Li L, Tian H, Wu L, Chen N, Zhang Q, Chen L, et al. Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk. Science Advances. 2025. doi:10.1126/sciadv.adr0377
BibTeX
@article{Li2025,
author = {Li, Lang and Tian, Hao and Wu, Liulin and Chen, Na and Zhang, Qiao and Chen, Lin and Zhu, Kai and Lin, Lin and Chen, Xi and He, Lang and Liu, Min and Zhao, Wenyan and Su, Yang and Yan, Juan and Zhao, Xingli and Zhou, Xin and Zhou, Zhenhua and Zeng, Wen},
title = {Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr0377}
}
EUVIMED